A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation

Oncotarget

Volumn 6, Issue 24, 2015, Pages 20037-20042

  Wienke, Judith ^a   Janssen, Willemijn ^a   Scholman, Rianne ^a   Spits, Hilde ^a   Gijn, Marielle van ^a   Boes, Marianne ^a   van Montfrans, Joris ^a   Moes, Nicolette ^b   de Roock, Sytze ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Autoimmunity; IL 17; IL 21; STAT3; Th17

Indexed keywords

ARGININE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 6; PROLINE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE REPORT; CD4+ T LYMPHOCYTE; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; IPEX SYNDROME; LYMPHOCYTE PROLIFERATION; REMISSION; SYMPTOMATOLOGY; T LYMPHOCYTE; TH17 CELL; GENETICS; IMMUNOLOGY; MUTATION; SIGNAL TRANSDUCTION;

ADOLESCENT; AUTOIMMUNITY; FEMALE; HUMANS; MUTATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS;

EID: 84940192631     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5042     Document Type: Article

References (10)

1. Flanagan SE, Haapaniemi E, Russell MA, Caswell R, Lango Allen H, De Franco E, et al. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat Genet. 2014;46:812-4.
2. Haapaniemi EM, Kaustio M, Rajala HL, van Adrichem AJ, Kainulainen L, Glumoff V, et al. Autoimmunity, hypogammaglobulinemia, lymphoproliferation and mycobacterial disease in patients with dominant activating mutations in STAT3. Blood. 2015;125:639-48.
3. Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015 Jan 22;125:591-9.
4. Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, et al. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol. 2007;179:4313-7.
5. Nijman IJ, van Montfrans JM, Hoogstraat M, Boes ML, van de Corput L, Renner ED, et al. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol. 2014;133:529-34.
6. Zhou L, Ivanov, II, Spolski R, Min R, Shenderov K, Egawa T, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8:967-74.
7. Tangye SG, Ma CS, Brink R, Deenick EK, The good, the bad and the ugly-TFH cells in human health and disease. Nat Rev Immunol. 2013;13:412-26.
8. Avery DT, Bryant VL, Ma CS, de Waal Malefyt R, Tangye SG. IL-21-Induced Isotype Switching to IgG and IgA by Human Naive B Cells Is Differentially Regulated by IL-4. J Immunol. 2008;181:1767-79.
9. Kane A, Deenick EK, Ma CS, Cook MC, Uzel G, Tangye SG. STAT3 is a central regulator of lymphocyte differentiation and function. Curr Opin Immunol. 2014;28:49-57.
10. de Jager W, Prakken BJ, Bijlsma JW, Kuis W, Rijkers GT. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods. 2005;300:124-35.